Tlabs Pharma Private Limited

Tlabs Pharma Private Limited - business services in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U74999MH2020PTC352775 Incorporated 30 December 2020 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company business services
Data last updated
Revenue · FY 2024
₹34.08 Lakh
▼ 12% YoY
Net loss · FY 2024
₹12.26 Lakh
Net margin -36%
EBITDA · FY 2024
-₹12.26 Lakh
EBITDA margin -36%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Tlabs Pharma Private Limited

Data last updated:

Tlabs Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 30 December 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC352775.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Teja Kalyani Ghanta and Manideep Batchu.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D 263 Office No 603 Akshar Blue Chip Turbhe Naka MIDC Navi Mumbai, Maharashtra, India – 400705.

As per the financials filed for FY 2024, the company reported a revenue of ₹34.08 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹12.26 Lakh (net margin -36%) and EBITDA of -₹12.26 Lakh (EBITDA margin -36%).

Company Details of Tlabs Pharma Private Limited
CIN U74999MH2020PTC352775
Registration Number 352775
Incorporation Date 30 December 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    D 263 Office No 603 Akshar Blue Chip Turbhe Naka MIDC Navi Mumbai, Maharashtra, India – 400705
  • Industry
    Business Services, Miscellaneous Business Activities, Other Services
Comprehensive company report
Tlabs Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Tlabs Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Tlabs Pharma Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Business Activity of Tlabs Pharma Private Limited

The main business activity of Tlabs Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Tlabs Pharma Private Limited FY 2024 filings available

Tlabs Pharma Private Limited reported revenue of ₹34.08 Lakh (down 12% YoY) for FY 2024.

Revenue · FY 2024
₹34.08 Lakh ▼ 12%
Net loss · FY 2024
₹12.26 Lakh margin -36%
EBITDA · FY 2024
-₹12.26 Lakh margin -36%

Compounded Annual Growth Rate (CAGR) of Tlabs Pharma Private Limited

Revenue CAGR growth
1 year
▼ 12%
EBITDA CAGR growth
1 year
▲ 28%
3 years · compounded
▼ 244%

Revenue fell 12% in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Tlabs Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••
Other Income••••••••••••••••
Total Revenue••••••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA-₹12.26 Lakh••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)-₹12.26 Lakh••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Tlabs Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-36%••••••••••••
Net Profit Margin-36%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tlabs Pharma are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Tlabs Pharma Private Limited

Tlabs Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Tapshila Life Care Private Limited₹34.2 Lakh (FY 2024)••••••••649.0%••••Parwanoo, Himachal Pradesh, India
Ulisses Pharmaceuticals Private Limited₹34.2 Lakh (FY 2025)••••••••-7.0%••••New Delhi, Delhi, India
Docx Animals Health Care Private Limited₹34.15 Lakh (FY 2025)••••••••9.0%••••Deodar, Gujarat, India
Swissol Chemicals (India) Private Limited₹34.14 Lakh (FY 2025)••••••••137.0%••••Mumbai, Maharashtra, India
Dr.Stanley Jones Siddha Pharmacy Private Limited₹34.08 Lakh (FY 2025)••••••••-19.0%••••Thiruvananthapuram, Kerala, India
Tlabs Pharma Private Limited this company₹34.08 Lakh (FY 2024)••••••••-12.0%••••Mumbai, Maharashtra, India
Skyway Coatings India Private Limited₹34.07 Lakh (FY 2024)••••••••-24.0%••••Nolambur, Mugapair, Chennai, Tamil Nadu, India
Zeylanica Pharmaceuticals Private Limited₹34.05 Lakh (FY 2025)••••••••9.0%••••Vadodara, Gujarat, India
Hasjis Healthcare Private Limited₹34.05 Lakh (FY 2025)••••••••7.0%••••Jaipur, Rajasthan, India
Truecos Pharmaceutical Private Limited₹34.02 Lakh (FY 2024)••••••••29.0%••••Ahmedabad, Gujarat, India
Troica Pigments Private Limited₹34.01 Lakh (FY 2021)••••••••-47.0%••••Delhi, India

Peers are the five companies nearest above and the five nearest below Tlabs Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Tlabs Pharma Private Limited

Tlabs Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Teja Kalyani GhantaDirector01 Jul 20233 Years 3 MonthsCurrent
Manideep BatchuDirector30 Dec 20205 Years 9 MonthsCurrent

Charges & Borrowings of Tlabs Pharma Private Limited

Tlabs Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Tlabs Pharma Private Limited

Employment history and EPFO contributions of people linked to Tlabs Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Tlabs Pharma Private Limited

Tlabs Pharma Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Teja Kalyani Ghanta was appointed as Director on 01 Jul 2023.

AGM
Tlabs Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Tlabs Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Appointed
Teja Kalyani Ghanta was appointed as Director.
Ceased
Menaka Sangem ceased to be Additional Director.
Ceased
Ashokkumar Akky ceased to be Director.
Appointed
Manideep Batchu was appointed as Director.
Incorporation
30 Dec 2020
Tlabs Pharma Private Limited was registered on 30 Dec 2020 with Roc Mumbai I & aged 5 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Tlabs Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Tlabs Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Tlabs Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Tlabs Pharma Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Tlabs Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tlabs Pharma Private Limited

Tlabs Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 30 December 2020 (6+ years old) and is registered under CIN U74999MH2020PTC352775.

Tlabs Pharma reported revenue of ₹34.08 Lakh for FY 2024 (down 12% YoY).

Tlabs Pharma has 2 current directors:

Tlabs Pharma reported a net loss of ₹12.26 Lakh (net margin -36%) and EBITDA of -₹12.26 Lakh (EBITDA margin -36%) for FY 2024, as per its filed financial statements.

The CIN (Corporate Identification Number) of Tlabs Pharma is U74999MH2020PTC352775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tlabs Pharma was incorporated on 30 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Tlabs Pharma by revenue are Tapshila Life Care Private Limited, Ulisses Pharmaceuticals Private Limited, Docx Animals Health Care Private Limited, Swissol Chemicals (India) Private Limited, Dr.Stanley Jones Siddha Pharmacy Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Teja Kalyani Ghanta was appointed as Director on 01 Jul 2023. Menaka Sangem ceased to be Additional Director on 30 Nov 2021. Ashokkumar Akky ceased to be Director on 02 Jun 2021. Tlabs Pharma has 4 board changes on record in total.

The registered office of Tlabs Pharma is at D 263 Office No 603 Akshar Blue Chip Turbhe Naka MIDC Navi Mumbai, Maharashtra, India – 400705.

Tlabs Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.

Tlabs Pharma operates in the business services industry, in the miscellaneous business activities segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available